Amber is an MSL and receives a physician question about a medication indication that is not FDA approved. Which statement is true?

Amber is an MSL and receives a physician question about a medication indication that is not FDA approved. Which statement is true?

• A. This is a routine marketing inquiry
• B. This is an unsolicited request
• C. This implies the product is approved for that indication
• D. This is a formal regulatory inquiry

Answer: (B)

When a physician asks about an indication that isn’t FDA-approved, the situation is an unsolicited request for medical information. The physician initiated the contact, and the MSL’s job is to respond with objective, evidence-based information from public sources without promotional language. This isn’t a routine marketing inquiry, because marketing discussions would revolve around approved uses and promotional messaging, not about off-label questions. It also doesn’t imply the product is approved for that indication—the labeling remains limited to FDA-approved indications. A formal regulatory inquiry would be directed to regulatory authorities (e.g., the FDA) rather than handled in a routine physician-Q&A with an MSL. So the true statement is that this is an unsolicited request.

When a physician asks about an indication that isn’t FDA-approved, the situation is an unsolicited request for medical information. The physician initiated the contact, and the MSL’s job is to respond with objective, evidence-based information from public sources without promotional language. This isn’t a routine marketing inquiry, because marketing discussions would revolve around approved uses and promotional messaging, not about off-label questions. It also doesn’t imply the product is approved for that indication—the labeling remains limited to FDA-approved indications. A formal regulatory inquiry would be directed to regulatory authorities (e.g., the FDA) rather than handled in a routine physician-Q&A with an MSL. So the true statement is that this is an unsolicited request.